Additionally, the company successfully expanded its operations by adding new sales territories and implant centers ... with obstructive sleep apnea. It offers inspire therapy, which consists ...

KeyBanc Capital Markets adjusted its price target on Inspire Medical Systems (NYSE:INSP) shares, lowering it to $234 from $236, while maintaining an Overweight rating on the stock. The revision ...

Beyond cardiovascular problems, untreated apnea can also lead to neurological issues ... Advanced treatments like Inspire Sleep, an FDA-approved implant that has shown success in the US and Europe, ...

Many major maladies have been linked to disturbed slumber caused by sleep apnea, high blood pressure, heart problems a ...

Her work has appeared in Women's Health, SELF, Prevention, The Washington Post, and more. Sleep apnea impacts about 30 million American adults, making it a common sleep disorder. But while plenty ...

Sleep apnea is a disorder that happens when your breathing is disrupted while you sleep. The condition affects sleep quality -- and it can also affect your pocketbook. An analysis by the American ...

Nearly 1 in 5 women and more than one-third of men in the United States have sleep apnea. This common sleep ... cases a surgical device called Inspire (hypoglossal nerve surgery) can be implanted.

The Food and Drug Administration (FDA) gave the green light to the the first-ever medication for obstructive sleep apnea (OSA). The newly approved drug, Zepbound (tirzepatide), targets adults with ...